Xconomy’s Digital Events →
Cellectar Biosciences is developing imaging compounds for detecting cancer. Credit: Photo of Circulating Tumor Cell cluster from the Kuhn Lab, http://kuhn.usc.edu
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Sponsored · Video
A Fireside Chat with Biocom President & CEO Joe Panetta
CMC in Drug Development and Life Cycle Management
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.